XML 57 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Debt Obligations (Tables)
12 Months Ended
Dec. 31, 2018
Schedule of Short-term Debt
a.

Short-term debt:

 

             December 31,  
     Weighted average
interest rate as of
December 31, 2018
    Maturity      2018      2017  
                  (U.S. $ in millions)  

Term loan JPY 28.3 billion

     JPY LIBOR+0.25     2018      $ —          251  

Bank and financial institutions

     6.79%       —          2        1  

Convertible debentures

     0.25%       2026        514        514  

Current maturities of long-term liabilities

 

     1,700        2,880  
  

 

 

    

 

 

 

Total short term debt

 

   $ 2,216      $ 3,646  
  

 

 

    

 

 

 
Schedule of Senior Notes and Loans
b.

Long-term debt:

 

     Weighted average
interest rate as of
December 31, 2018
  Maturity    December 31,
2018
    December 31,
2017
 
     %        (U.S. $ in millions)  

Senior notes EUR 1,660 million (8)

   0.38%   2020    $ 1,897     $ 2,095  

Senior notes EUR 1,500 million

   1.13%   2024      1,707       1,788  

Senior notes EUR 1,300 million

   1.25%   2023      1,480       1,550  

Senior notes EUR 1,000 million (3)

   2.88%   2019      —         1,199  

Senior notes EUR 900 million (1)

   4.50%   2025      1,029       —    

Senior notes EUR 750 million

   1.63%   2028      850       891  

Senior notes EUR 700 million (1)

   3.25%   2022      801       —    

Senior notes EUR 700 million

   1.88%   2027      798       837  

Senior notes USD 3,500 million

   3.15%   2026      3,493       3,492  

Senior notes USD 3,000 million

   2.20%   2021      2,997       2,996  

Senior notes USD 3,000 million

   2.80%   2023      2,993       2,992  

Senior notes USD 1,700 million (8)

   1.70%   2019      1,700       2,000  

Senior notes USD 2,000 million

   4.10%   2046      1,985       1,984  

Senior notes USD 1,500 million (3)

   1.40%   2018      —         1,500  

Senior notes USD 1,250 million (2)

   6.00%   2024      1,250       —    

Senior notes USD 1,250 million (2)

   6.75%   2028      1,250       —    

Senior notes USD 844 million

   2.95%   2022      860       864  

Senior notes USD 789 million

   6.15%   2036      782       781  

Senior notes USD 700 million

   2.25%   2020      700       700  

Senior notes USD 613 million

   3.65%   2021      621       624  

Senior notes USD 588 million

   3.65%   2021      587       587  

Senior notes CHF 450 million (10)

   1.50%   2018      —         461  

Senior notes CHF 350 million

   0.50%   2022      356       360  

Senior notes CHF 350 million

   1.00%   2025      356       360  

Senior notes CHF 300 million (9)

   0.13%   2018      —         308  

Fair value hedge accounting adjustments

          (9     (2
       

 

 

   

 

 

 

Total senior notes

          28,483       28,367  

Term loan USD 2.5 billion (4)

   LIBOR +1.1375%   2018      —         285  

Term loan USD 2.5 billion (4)

   LIBOR +1.50%   2017-2020      —         2,000  

Term loan JPY 58.5 billion (5)

   JPY LIBOR +0.55%   2022      —         519  

Term loan JPY 35 billion (6)

   1.42%   2019      —         311  

Term loan JPY 35 billion (6)

   JPY LIBOR +0.3%   2018      —         311  
       

 

 

   

 

 

 

Total loans

          —         3,426  

Debentures USD 15 million (7)

   7.20%   2018      —         15  

Other

   4.79%   2026      12       5  
       

 

 

   

 

 

 

Total debentures and others

          12       20  
       

 

 

   

 

 

 

Less current maturities

          (1,700     (2,880

Derivative instruments

          9       2  

Less debt issuance costs

          (104     (106
       

 

 

   

 

 

 

Total senior notes and loans

        $ 26,700     $ 28,829  
       

 

 

   

 

 

 

 

(1)

In March 2018, Teva Pharmaceutical Finance Netherlands II B.V., a Teva finance subsidiary, issued senior notes in an aggregate principal amount of €1.6 billion.

(2)

In March 2018, Teva Pharmaceutical Finance Netherlands III B.V., a Teva finance subsidiary, issued senior notes in an aggregate principal amount of $2.5 billion.

(3)

In March 2018, Teva redeemed in full its $1.5 billion 1.4% senior notes due in July 2018 and its €1.0 billion 2.88% senior notes due in April 2019.

(4)

During the first quarter of 2018, Teva prepaid approximately $2.3 billion principal amount of the remaining term loan facilities.

(5)

During the first quarter of 2018, Teva prepaid in full JPY 86.8 billion principal amount of the outstanding term loan facilities of which JPY 28.3 billion were in short-term debt as of December 31, 2017.

(6)

During the first quarter of 2018, Teva prepaid in full JPY 70 billion of its 1.42% and JPY LIBOR+0.3% outstanding term loans.

(7)

During the first quarter of 2018, Teva prepaid in full $15 million of its outstanding debentures.

(8)

In September 2018, Teva consummated a cash tender offer for certain of its outstanding senior notes. As a result of the offer, Teva redeemed $300 million aggregate principal amount of its 1.7% senior notes and €90 million principal amount of its 0.38% senior notes.

(9)

In July 2018, Teva repaid at maturity CHF 300 million of its 0.13% senior notes.

(10)

In October 2018, Teva repaid at maturity CHF 450 million of its 1.5% senior notes.

Required Annual Principal Payments of Long-term Debt, Excluding Debt Issuance Cost

The required annual principal payments of long-term debt, excluding debt issuance cost as of December 31, 2018, starting with the year 2020, are as follows:

 

     December 31,
2018
 
     (U.S. $ in millions)  

2020

   $ 2,596  

2021

     4,205  

2022

     2,017  

2023

     4,473  

2024 and thereafter

     13,513  
  

 

 

 
   $ 26,804